Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam M Deane

Showing results (131-140 of 259) with videos related to

Pageof 26
Sort By:
Critical Care Medicine|April 6, 2016
Liberal Versus Conventional Glucose Targets in Critically Ill Diabetic Patients: An Exploratory Safety Cohort AssessmentFrancesca Di Muzio, Barbara Presello, Neil J Glassford, et al.
The Journal of Clinical Endocrinology and Metabolism|November 26, 2014
Accelerated intestinal glucose absorption in morbidly obese humans: relationship to glucose transporters, incretin hormones, and glycemiaNam Q Nguyen, Tamara L Debreceni, Jenna E Bambrick, et al.
Obesity (Silver Spring, Md.)|July 4, 2014
Upregulation of intestinal glucose transporters after Roux-en-Y gastric bypass to prevent carbohydrate malabsorptionNam Q Nguyen, Tamara L Debreceni, Jenna E Bambrick, et al.
Diabetologia|June 7, 2015
Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetesLaurence G Trahair, Michael Horowitz, Julie E Stevens, et al.
American Journal of Respiratory and Critical Care Medicine|September 23, 2024
Virtual Peer Support for ICU Survivors Is Feasible and May Improve Outcomes for ICU Survivors: Results from the icuRESOLVE-D (icu Recovery Solutions Codesigned through Survivor Engagement - Digital) Pilot Randomized Controlled TrialNina Leggett, Yasmine Ali Abdelhamid, Erin Bicknell, et al.
Critical Care Medicine|June 18, 2016
Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory StudyPalash Kar, Mark P Plummer, Rinaldo Bellomo, et al.
Hepatology (Baltimore, Md.)|April 2, 2019
Gallbladder Dyskinesia Is Associated With an Impaired Postprandial Fibroblast Growth Factor 19 Response in Critically Ill PatientsKiran V K Koelfat, Mark P Plummer, Frank G Schaap, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
Communication with bereaved family members after death in the ICU: the CATHARTIC randomised clinical trialLaurie Showler, Louise Rait, Michael Chan, et al.
Diabetologia|February 3, 2016
The insulinotropic effect of pulsatile compared with continuous intravenous delivery of GLP-1Mark P Plummer, Palash Kar, Caroline E Cousins, et al.
Critical Care (London, England)|January 25, 2011
Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetesAdam M Deane, Matthew J Summers, Antony V Zaknic, et al.
Pageof 26

Showing results (131-140 of 259) with videos related to

Sort By:
Pageof 26
Critical Care Medicine|April 6, 2016
Liberal Versus Conventional Glucose Targets in Critically Ill Diabetic Patients: An Exploratory Safety Cohort AssessmentFrancesca Di Muzio, Barbara Presello, Neil J Glassford, et al.
The Journal of Clinical Endocrinology and Metabolism|November 26, 2014
Accelerated intestinal glucose absorption in morbidly obese humans: relationship to glucose transporters, incretin hormones, and glycemiaNam Q Nguyen, Tamara L Debreceni, Jenna E Bambrick, et al.
Obesity (Silver Spring, Md.)|July 4, 2014
Upregulation of intestinal glucose transporters after Roux-en-Y gastric bypass to prevent carbohydrate malabsorptionNam Q Nguyen, Tamara L Debreceni, Jenna E Bambrick, et al.
Diabetologia|June 7, 2015
Effects of exogenous glucagon-like peptide-1 on blood pressure, heart rate, gastric emptying, mesenteric blood flow and glycaemic responses to oral glucose in older individuals with normal glucose tolerance or type 2 diabetesLaurence G Trahair, Michael Horowitz, Julie E Stevens, et al.
American Journal of Respiratory and Critical Care Medicine|September 23, 2024
Virtual Peer Support for ICU Survivors Is Feasible and May Improve Outcomes for ICU Survivors: Results from the icuRESOLVE-D (icu Recovery Solutions Codesigned through Survivor Engagement - Digital) Pilot Randomized Controlled TrialNina Leggett, Yasmine Ali Abdelhamid, Erin Bicknell, et al.
Critical Care Medicine|June 18, 2016
Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory StudyPalash Kar, Mark P Plummer, Rinaldo Bellomo, et al.
Hepatology (Baltimore, Md.)|April 2, 2019
Gallbladder Dyskinesia Is Associated With an Impaired Postprandial Fibroblast Growth Factor 19 Response in Critically Ill PatientsKiran V K Koelfat, Mark P Plummer, Frank G Schaap, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
Communication with bereaved family members after death in the ICU: the CATHARTIC randomised clinical trialLaurie Showler, Louise Rait, Michael Chan, et al.
Diabetologia|February 3, 2016
The insulinotropic effect of pulsatile compared with continuous intravenous delivery of GLP-1Mark P Plummer, Palash Kar, Caroline E Cousins, et al.
Critical Care (London, England)|January 25, 2011
Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetesAdam M Deane, Matthew J Summers, Antony V Zaknic, et al.
Pageof 26